OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical outcomes associated with drugs for obesity and overweight: A systematic review and network meta‐analysis of randomized controlled trials
Andrea Iannone, Patrizia Natale, Suetonia C. Palmer, et al.
Diabetes Obesity and Metabolism (2023) Vol. 25, Iss. 9, pp. 2535-2544
Open Access | Times Cited: 15

Showing 15 citing articles:

Semaglutide (Ozempic®) Use in Denmark 2018 Through 2023 ‒ User Trends and off-Label Prescribing for Weight Loss
Aurélie Mailhac, Lars C. Pedersen, Anton Pottegård, et al.
Clinical Epidemiology (2024) Vol. Volume 16, pp. 307-318
Open Access | Times Cited: 17

The Lancet Commission on rethinking coronary artery disease: moving from ischaemia to atheroma
Sarah Zaman, Jason H. Wasfy, Vikas Kapil, et al.
The Lancet (2025)
Closed Access | Times Cited: 1

Real‐world evidence on the utilization, clinical and comparative effectiveness, and adverse effects of newer GLP1RA‐based weight‐loss therapies
Reimar W. Thomsen, Aurélie Mailhac, Julie B. Løhde, et al.
Diabetes Obesity and Metabolism (2025)
Open Access | Times Cited: 1

Medicines for the management of overweight and obesity: A systematic review with network meta-analysis
Gabriela Masiero Marcon, Jhonatan Mendes Paiva, Mariana Delariva Sakiyama, et al.
Brazilian Journal of Pharmaceutical Sciences (2025) Vol. 61
Open Access

Efficacy of Oral Medication in Weight Loss Management: A Systematic Review and Network Meta-Analysis
Benedictus Benedictus, V. Pratama, Christopher William Purnomo, et al.
Clinical Therapeutics (2025)
Closed Access

Tackling the complexity of obesity in the US through adaptation of public health strategies
Jamy D. Ard, Amber Huett-Garcia, Michele Bildner
Frontiers in Public Health (2025) Vol. 13
Open Access

Incretin-based therapies for the treatment of obesity-related diseases
Irene Caruso, Angelo Cignarelli, Gian Pio Sorice, et al.
npj Metabolic Health and Disease (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 3

Adverse effects with semaglutide: a protocol for a systematic review with meta-analysis and trial sequential analysis
Christina Dam Bjerregaard Sillassen, Caroline Kamp Jørgensen, Johanne Juul Petersen, et al.
BMJ Open (2024) Vol. 14, Iss. 6, pp. e084190-e084190
Open Access | Times Cited: 1

Associations of Food Addiction Symptomatology and Disordered Eating Behaviors in a Pre-Surgical Bariatric Population
Melissa Butt, Paddy Ssentongo, Ann M. Rogers, et al.
Nutrients (2023) Vol. 15, Iss. 15, pp. 3474-3474
Open Access | Times Cited: 3

Semaglutide: The First Anti-Obesity Agent Shown to Decrease Cardiovascular Events
Nasser Mikhail, Soma Wali
Annals of Cardiovascular Diseases (2024) Vol. 8, Iss. 1, pp. 1-4
Open Access

Semaglutide: The First Anti-Obesity Agent Shown to Decrease Cardiovascular Events
Nasser Mikhail, Soma Wali
Annals of Cardiovascular Diseases (2024) Vol. 8, Iss. 1, pp. 1-4
Open Access

Effective medical treatment of obesity among immigrant women in primary care
Wudeneh Mulugeta
Obesity Pillars (2024) Vol. 12, pp. 100132-100132
Open Access

The real‐world relationship between naltrexone/bupropion treatment and weight loss in Canada: A retrospective chart review
Sean Wharton, Elham Kamran, Lehana Thabane, et al.
Clinical Obesity (2024)
Closed Access

Page 1

Scroll to top